The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Share News (VAL)

Share Price Information for ValiRx (VAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.25
Bid: 3.20
Ask: 3.30
Change: 0.00 (0.00%)
Spread: 0.10 (3.125%)
Open: 3.25
High: 3.25
Low: 3.25
Prev. Close: 3.25
VAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS: Telecity Shares Jump 14% On Interxion Takeover

Wed, 11th Feb 2015 11:55

LONDON (Alliance News) - The following stocks are amongst the biggest risers and fallers within the main London indices midday Wednesday.
-------
FTSE 100 WINNERS
-------
ARM Holdings, up 4.2%. The chip designer raised its dividend as it posted an increase in profit for 2014, boosted by strong licence revenue growth and improved royalty revenue growth in its fourth quarter, and said it expects to meet market expectations for dollar revenues in 2015.

Reckitt Benckiser Group, up 3.3%. The consumer goods group's fourth-quarter net revenue growth beat market expectations, and the group announced further cost-cutting initiatives and plans to bolster its share-buyback programme in 2015.

BT Group, up 2.5%. The company secured 42 English Premier League football games a season, up from its current 38 games for a cost of GBP320 million per year. BT won a live Saturday evening game each week during the Premier League season, which will allow the company to "build on its current Saturday programming and appeal to an even larger audience, having secured the prime evening TV viewing slot," it said in a statement.

United Utilities, up 1.7%. The utility company has been raised to Neutral from Underweight by HSBC, which also raised its price target on the stock to 1,000.00 pence from 860.00p. The company currently trades at 976.51p.
-------
FTSE 100 LOSERS
-------
Sky, down 3.6%. The broadcaster secured five of the seven Premier League packages available, equating to 126 live games per season from a total 168 matches, for a cost of GBP1.32 billion per year, representing an 83% increase from the cost of its existing contract. "BT's opposing price reaction to Sky says it all with BT in the ascendance. BT keeps the pressure up on Sky, securing only marginally more games than before but continually moving forward with their 'quad-play' plans," says William Nicholls, a dealer at London Capital Group.

Tullow Oil, down 2.9%. The oil exploration and production company suspended its final dividend for 2014. It swung to a pretax loss after booking significant impairment charges, combined with falling production and revenue in the year.

Schroders, down 1.2%. The asset manager has been cut to Underweight from Overweight by HSBC.
-------
FTSE 250 WINNERS
-------
Telecity Group, up 14%. The data centre operator has agreed to take over European data centre services provider Interxion Holding NV in an all-share merger. It also posted a lower profit for 2014 due to exceptional costs mostly relating to its Turkish business but said it will begin a GBP400 million share buy-back programme over three years.

Redrow, up 11%. The housebuilder doubled its interim dividend, as it reported its pretax profit also nearly doubled on the back of higher revenue and a rise in sales in the first half.

Dunelm Group, up 5.0%. The homewares retailer delivered a higher first-half profit, driven by a 14% increase in revenue, helped by new store openings and strong growth online. However, the group cautioned that it expects benefits of top-line growth in the remainder of the financial year to be largely offset by higher operating costs, saying it expects to return to stronger profit growth next year.

Vedanta Resources, up 2.2%. The company has been raised to Equal-Weight from Underweight by Morgan Stanley.
-------
FTSE 250 LOSERS
-------
Indivior, down 6.3%. The pharmaceutical firm, which was spun-off by Reckitt Benckiser Group, posted a lower pretax profit for 2014 due to generic competition in the US and price cuts in Europe hitting its revenue in the US and exceptional costs relating to the de-merger.

Lonmin, down 5.7%. Glencore said it will divest from its 23.9% stake in platinum miner Lonmin during the first half of 2015 by distributing Lonmin shares to Glencore shareholders.

Poundland Group, down 5.5%. US private equity firm Warburg Pincus sold a larger-than-expected stake in retailer Poundland Group, sending shares in the company lower.

Thomas Cook Group, down 4.9%. The travel operator said it cut its first quarter operating loss by more than 40% on the year before, as it continued to cut out costs across the business, but cited pricing and competitive pressures, and tough trading in continental Europe. The group said tough trading conditions, particularly in Continental Europe have hit prices, partially offsetting the positive effects of further cost savings and the benefits of lower fuel costs.

Electrocomponents, down 4.8%. The electronics company said it had seen sales growth ramp up in the four months to end-January, up 5% compared to growth of 3% in its first half. It said there was one less trading day in the period compared to the previous year, and as a result it expects its pretax profit for the year to be hit by around GBP2 million due to the fewer trading days.

Cobham, down 2.5%. The engineering company said it will book a charge in its 2014 results related to its air-to-air refuelling development programmes and said the same problems have resulted in contract delays. It said it will recognise a GBP15 million one-off pretax provision in its underlying results for the year to the end of December.
-------
AIM ALL-SHARE WINNERS
-------
DP Poland, up 62%. The company, which sub-franchises Domino's Pizza stores in Poland, reported a jump in sales and profit in the year to the end of December. It said its system sales in the year to the end of December rose 35% to PLN20.4 million from PLN15.1 million a year earlier.

Tertiary Minerals, up 13%. The company posted positive results for the phase three drilling programme at the MB fluorspar project in Nevada. Drilling at Holes 14TMBRC030, 14TMBRC032 and 14TMBRC033 all encountered fluorspar intersections and demonstration continuity of the mineralisation to the west of the central area of the prospect.

Red24, up 13%. The crisis assistance company said it expects to beat expectations for the full year on the back of new business wins and a busy third quarter.

ValiRx, up 10%. The life sciences company said it has been handed patent approval from the European Patent Office for a biomarker testing process. The patent covers the means for diagnosing and monitoring of patients using biomarker testing for B-cell lymphomas and its prognostic outcome, ValiRx said.

Styles & Wood Group, up 8.6%. The property services company said its full-year trading was in line with expectations on the back of a rise in revenue in the second half. The group said the rise in revenue seen in the second half of the year to the end of December has continued into 2015, with increasing activity levels and confidence in its core markets.
-------
AIM ALL-SHARE LOSERS
-------
Trap Oil Group, off 57%. The company said it has relinquished its interest in one license in the UK North Sea at a cost of USD5.8 million and said it is incurring a significant loss on another field due to the low oil price environment.

Tangent Communications, down 28%. The marketing platforms and services provider said that it now expects to post an underlying operating profit of GBP1.2 million for the year to end-February, down from the previous year, and said it does not expect to propose a final dividend.
-------
By Neil Thakrar; neilthakrar@alliancenews.com; @NeilThakrar1

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
21 Mar 2024 11:22

ValiRx inks evaluation deal with Imperial College London for research

(Alliance News) - ValiRx PLC on Thursday said that it has signed an evaluation deal with Imperial College London to look at research on novel therapeutic candidates for cancer treatment.

Read more
19 Mar 2024 19:47

EARNINGS AND TRADING: Ten Lifestyle sees profit up but sales flat

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
13 Feb 2024 14:45

ValiRx says requisition notice from shareholder group is invalid

(Alliance News) - ValiRx PLC on Tuesday said a requisition notice, which it received earlier in February, has been confirmed as invalid following legal advice.

Read more
12 Feb 2024 12:59

ValiRx inks deal with Dundee Drug Discovery Unit

(Sharecast News) - ValiRx announced the signing of a significant agreement with the University of Dundee and its Drug Discovery Unit (DDU) on Monday.

Read more
12 Feb 2024 11:42

IN BRIEF: ValiRx signs research sharing deal with Dundee University

ValiRx PLC - Nuneaton, England-based life sciences company focused on early-stage cancer therapeutics - Signs agreement with Dundee University's drug discovery unit to access research concerning novel therapeutic candidates. The agreement will be active for a period of five years, in which ValiRx may review research projects from the unit in areas aligned with the company's focus on cancer therapeutics.

Read more
9 Feb 2024 20:24

TRADING UPDATES: ValiRx receives shareholder request for board change

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
28 Dec 2023 15:56

UK shareholder meetings calendar - next 7 days

Friday 29 December 
Apollon Formularies PLCAGM
Eco Atlantic Oil & Gas LtdAGM
Genedrive PLCAGM
Goldplat PLCAGM
Lansdowne Oil & Gas PLCGM re capital raise
Marula Mining PLCAGM
Microsaic Systems PLCGM re fundraise
Online Blockchain PLCAGM
Secure Property Development & Investment PLCAGM
SkinBioTherapeutics PLCAGM
Tetragon Financial Group LtdAGM
Woodbois LtdAGM
Zambeef Products PLCAGM
Monday 1 January 
no events scheduled 
Tuesday 2 January 
no events scheduled 
Wednesday 3 January 
Jubilee Metals Group PLCGM re equity raise
Thursday 4 January 
Rotala PLCGM re management buyout
Tintra PLCGM re cancellation, re-registering as private company
ValiRx PLCGM re operational review
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
19 Dec 2023 20:46

IN BRIEF: ValiRx raises GBP192,200, part of wider GBP1.8 million raise

ValiRx PLC - life science company based near Birmingham, England, which is focused on early-stage cancer therapeutics and women's health - Says 3.2 million new shares have been subscribed for at 6 pence per share via a retail offer, raising GBP192,244. Also issues 499,998 new shares via a subscription. In total, raises GBP1.8 million via placing, subscription and retail offer of 30.0 million new shares.

Read more
13 Dec 2023 21:14

TRADING UPDATES: Good Energy says ZapMap expands into mainland Europe

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
5 Dec 2023 15:08

ValiRx enters option deal with Ambrose Healthcare

(Sharecast News) - Cancer therapeutics-focussed life science company ValiRx announced on Tuesday that its subsidiary ValiSeek has entered into an exclusive option agreement with Ambrose Healthcare, a private UK-based pharmaceutical company.

Read more
5 Dec 2023 11:17

ValiRx says ValiSeek inks deal to licence VAL401 drug with Ambrose

(Alliance News) - ValiRx PLC on Tuesday said that ValiSeek Ltd it has entered a deal to licence VAL401 with Ambrose Healthcare Ltd, a private UK specialist pharmaceutical company.

Read more
5 Dec 2023 10:59

AIM WINNERS & LOSERS: tinyBuild warns on revenue; ValiRx rises

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Read more
10 Nov 2023 11:49

ValiRx signs deal to evaluate StingRay Bio drug candidates

(Alliance News) - ValiRx PLC on Friday said it has signed a deal with StingRay Bio Ltd to investigate a series of drug candidates.

Read more
10 Nov 2023 10:32

ValiRx enters partnership with StingRay Bio

(Sharecast News) - Life science company ValiRx announced a new partnership with StingRay Bio on Friday, aiming to explore a promising lead series of drug candidates designed for oncology applications.

Read more
6 Oct 2023 11:35

ValiRx sees no reason for shares jump; notes TheoremRx mulls merger

(Alliance News) - ValiRx PLC on Friday said it had no unpublished information that was sensitive to its share price, as it rose significantly.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.